BLOOD SUGAR LEVEL CONTROLLING AGENT

A blood glucose level controlling agent for a diabetic patient to be insulinized, which comprises as the active ingredient an insulin receptor agonist and a neurotrophin; a use of these two ingredients in preparation of said blood glucose level controlling agent; and a method for controlling the blo...

Full description

Saved in:
Bibliographic Details
Main Authors NOGUCHI, HIROSHI, TAIJI, MUTSUO, NAKAGAWA, TSUTOMU, NAKAYAMA, CHIKAO
Format Patent
LanguageEnglish
French
German
Published 17.11.2004
Edition7
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract A blood glucose level controlling agent for a diabetic patient to be insulinized, which comprises as the active ingredient an insulin receptor agonist and a neurotrophin; a use of these two ingredients in preparation of said blood glucose level controlling agent; and a method for controlling the blood glucose level of a diabetic patient within the normal range by using these two ingredients. By administering the pharmaceutical composition of the present invention for controlling the blood glucose lever of a patient to be insulinized, the effect of insulin is enhanced, while side effects thereof such as hypoglycemic shock are eased, thereby also enabling improvement in the compliance.
AbstractList A blood glucose level controlling agent for a diabetic patient to be insulinized, which comprises as the active ingredient an insulin receptor agonist and a neurotrophin; a use of these two ingredients in preparation of said blood glucose level controlling agent; and a method for controlling the blood glucose level of a diabetic patient within the normal range by using these two ingredients. By administering the pharmaceutical composition of the present invention for controlling the blood glucose lever of a patient to be insulinized, the effect of insulin is enhanced, while side effects thereof such as hypoglycemic shock are eased, thereby also enabling improvement in the compliance.
Author TAIJI, MUTSUO
NAKAYAMA, CHIKAO
NAKAGAWA, TSUTOMU
NOGUCHI, HIROSHI
Author_xml – fullname: NOGUCHI, HIROSHI
– fullname: TAIJI, MUTSUO
– fullname: NAKAGAWA, TSUTOMU
– fullname: NAKAYAMA, CHIKAO
BookMark eNrjYmDJy89L5WRQdvLx93dRCA51dwxS8HENc_VRcPb3Cwny9_Hx9HNXcHR39QvhYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgGGhgZmhhZGjibGRCgBAPBRJAA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate AGENT DE REGULATION DU TAUX DE GLYCEMIE
WIRKSTOFF ZUR KONTROLLE DES BLUTZUCKERSPIEGELS
Edition 7
ExternalDocumentID EP1106182A4
GroupedDBID EVB
ID FETCH-epo_espacenet_EP1106182A43
IEDL.DBID EVB
IngestDate Fri Jul 19 16:00:50 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP1106182A43
Notes Application Number: EP19990937009
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20041117&DB=EPODOC&CC=EP&NR=1106182A4
ParticipantIDs epo_espacenet_EP1106182A4
PublicationCentury 2000
PublicationDate 20041117
PublicationDateYYYYMMDD 2004-11-17
PublicationDate_xml – month: 11
  year: 2004
  text: 20041117
  day: 17
PublicationDecade 2000
PublicationYear 2004
RelatedCompanies SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
RelatedCompanies_xml – name: SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
Score 2.612964
Snippet A blood glucose level controlling agent for a diabetic patient to be insulinized, which comprises as the active ingredient an insulin receptor agonist and a...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title BLOOD SUGAR LEVEL CONTROLLING AGENT
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20041117&DB=EPODOC&locale=&CC=EP&NR=1106182A4
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5qFfWmVWl9saDkFiTv5BAk7yI1G2IqvZXdTQq91GIj_n0nsale9LbswuwDvp35ducBcF-qXBg2Q25iCVXWBbNlW5TIeZhVCtM0uFq1Xr6pOZ7qTzNj1oNlFwvT5gn9bJMjIqIE4r1u7-v1zyNW2PpWbh74ErveHuPCDaWOHesIXUsKfTfKaEgDKQiwJaW5qzTUx1Y9fQ_20Yq2Gu-v6NVvglLWvzVKfAIHGQpb1afQq1YDOAq6wmsDOHze_ndjcwu9zRnc-RNKQ_IyTbycTJrSmSSgaZFTZONpQrwkSotzIHFUBGMZZ5vvdjaPst26tAvoI-GvhkBMR-NM52iYMIH6ljkLlakOYwrXTU1Z8BGM_hRz-c_YFRx_pylUZMW6hn79_lHdoEqt-W17GF9Ai3cJ
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5qFetNq9L6DCi5Bck7OQTJO2iahJhKb2V3k0IvtdiIf99JbKoXvQ27MDu7MDvz7c4D4L6UKFMNgthEZ5KgMGIIBisR8xC9ZJqmUqlqo3wTLZoqTzN11oNllwvT1gn9bIsjokYx1Pe6va_XP49YXhtbuXmgSxx6ewwKy-M7dKyg6uq851h-lnqpy7suUnySW2IDfQzJVvZgHz1soymz7786TVLK-rdFCY7hIENmq_oEetVqCAO3a7w2hMPJ9r8bya3qbU7hzonT1ONepqGdc3HTOpNz06TIU0TjScjZoZ8UZ8AFfuFGAq423-1s7mc7ueRz6CPgr0bAaaZMiULRMSEM7S0xFxKRTEJEqmiyuKBjGP_J5uKfuVsYRMUknqNYz5dw9F2yUBRE_Qr69ftHdY3mtaY37cF8Afzmefk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=BLOOD+SUGAR+LEVEL+CONTROLLING+AGENT&rft.inventor=NOGUCHI%2C+HIROSHI&rft.inventor=TAIJI%2C+MUTSUO&rft.inventor=NAKAGAWA%2C+TSUTOMU&rft.inventor=NAKAYAMA%2C+CHIKAO&rft.date=2004-11-17&rft.externalDBID=A4&rft.externalDocID=EP1106182A4